Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Matter

Showing results (301-310 of 324) with videos related to

Pageof 33
Sort By:
JACC. Cardiovascular Interventions|July 25, 2015
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational StudyLorenz Räber, Roland Klingenberg, Dik Heg, et al.
JAMA|August 23, 2012
Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trialLorenz Räber, Henning Kelbæk, Miodrag Ostojic, et al.
Heart (British Cardiac Society)|March 22, 2015
Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in SwitzerlandRoland Klingenberg, Dik Heg, Lorenz Räber, et al.
Circulation|February 13, 2015
Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1Elena Osto, Petia Doytcheva, Caroline Corteville, et al.
European Heart Journal|October 12, 2019
Endothelial SIRT6 blunts stroke size and neurological deficit by preserving blood-brain barrier integrity: a translational studyLuca Liberale, Daniel S Gaul, Alexander Akhmedov, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|September 18, 2020
[EUROCRINE®: adrenal surgery 2015-2019- surprising initial results]J I Staubitz, T Clerici, P Riss, et al.
Thrombosis and Haemostasis|December 21, 2019
Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3Alexander Akhmedov, Fabrizio Montecucco, Sarah Costantino, et al.
The Journal of Clinical Investigation|June 25, 2011
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery diseaseChristian Besler, Kathrin Heinrich, Lucia Rohrer, et al.
Journal of Molecular and Cellular Cardiology|January 24, 2020
Sirt6 deletion in bone marrow-derived cells increases atherosclerosis - Central role of macrophage scavenger receptor 1Tasneem Arsiwala, Jürgen Pahla, Lambertus J van Tits, et al.
American Heart Journal|May 5, 2021
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trialChristian Zanchin, Konstantinos C Koskinas, Yasushi Ueki, et al.
Pageof 33

Showing results (301-310 of 324) with videos related to

Sort By:
Pageof 33
JACC. Cardiovascular Interventions|July 25, 2015
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational StudyLorenz Räber, Roland Klingenberg, Dik Heg, et al.
JAMA|August 23, 2012
Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trialLorenz Räber, Henning Kelbæk, Miodrag Ostojic, et al.
Heart (British Cardiac Society)|March 22, 2015
Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in SwitzerlandRoland Klingenberg, Dik Heg, Lorenz Räber, et al.
Circulation|February 13, 2015
Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1Elena Osto, Petia Doytcheva, Caroline Corteville, et al.
European Heart Journal|October 12, 2019
Endothelial SIRT6 blunts stroke size and neurological deficit by preserving blood-brain barrier integrity: a translational studyLuca Liberale, Daniel S Gaul, Alexander Akhmedov, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|September 18, 2020
[EUROCRINE®: adrenal surgery 2015-2019- surprising initial results]J I Staubitz, T Clerici, P Riss, et al.
Thrombosis and Haemostasis|December 21, 2019
Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3Alexander Akhmedov, Fabrizio Montecucco, Sarah Costantino, et al.
The Journal of Clinical Investigation|June 25, 2011
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery diseaseChristian Besler, Kathrin Heinrich, Lucia Rohrer, et al.
Journal of Molecular and Cellular Cardiology|January 24, 2020
Sirt6 deletion in bone marrow-derived cells increases atherosclerosis - Central role of macrophage scavenger receptor 1Tasneem Arsiwala, Jürgen Pahla, Lambertus J van Tits, et al.
American Heart Journal|May 5, 2021
Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trialChristian Zanchin, Konstantinos C Koskinas, Yasushi Ueki, et al.
Pageof 33